Your selection
Research / 06.02.2026
Professorship awarded to Mina Gouti
Mina Gouti has been awarded a professorship at Charité – Universitätsmedizin Berlin. The appointment will strengthen her pioneering organoid research at the Max Delbrück Center and deepen collaboration with clinicians to advance personalized medicine.
Dr. Mina Gouti, Group Leader of the Stem Cell Modeling of Development and Disease lab at the Max Delbrück Center, has been appointed W3 Professor of Complex Organoid Models for Personalized Medicine in the Medical Faculty, Charité – Universitätsmedizin Berlin. The permanent position recognizes her achievements in developing advanced organoid systems to understand how specific types of spinal cord neurons and skeletal muscle cells grow in space and time during development.
“This professorship will enable my team to fully leverage Berlin’s exceptional biomedical ecosystem and to work closely with clinicians at Charité to create complex organoids for personalized medicine,” Gouti says. This close interaction is essential for translating patient-derived organoid models into clinically relevant insights.”
The Gouti lab has developed three-dimensional neuromuscular organoids from human pluripotent stem cells that replicate key features of spinal cord neurons and skeletal muscle – providing powerful platforms for studying neuromuscular diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis, and for drug screening. Such organoids can also be grown from cells derived from individual patients to model their specific disease.
The position reflects a shared vision between the Max Delbrück Center and Charité to accelerate translational research through fostering closer collaboration between clinicians researchers. “We now have the long-term perspective required to develop complex, functional organoids as predictive platforms for personalized medicine and early disease interception,” says Gouti. “We hope our research will lead to better health outcomes not only for people with neuromuscular diseases, but also those at high risk of developing them.”
Text: Gunjan Sinha
Further information
Overview News
News Buch Berlin
“The coolest part is vortexing”
One week, two topics, and plenty of new experiences: 25 young people take a deep dive into research on rare diseases and immunology at the Life Science Learning Lab “Gläsernes Labor,” including by ana...
more ...Kirstin Bodensiek appointed Administrative Director
As of August 15, 2026, Kirstin Bodensiek has officially taken the helm as Administrative Director of the Max Delbrück Center. She is stepping into the permanent position after leading the center on an...
more ...Eckert & Ziegler Remains on Track in the First Half of 2026
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) reported sales of €149.3 million in the first half of 2026. The group’s adjusted EBIT dropped by just under 6% to €33.3 million. Adjusted EBIT in the Me...
more ...Events Buch Berlin
17.09.2026, 17:00
Talk in the Cube: AI in Biotech
With this edition of Talk in the Cube, we want to capture exactly the range from biomarker discovery and a new AI research assistant, to public health imaging, to industrial-scale protein design. Thre...
more ...19.09.2026, 10:00
Tag der offenen Türen: Montessori-Gemeinschaftsschule und -Kinderhaus und Kita Baum und Borke
Am Samstag, 19. September 2026, von 10:00 bis 13:00 Uhr öffnen drei KARUNA-Bildungseinrichtungen im Ludwig Hoffmann Quartier gemeinsam ihre Türen.
more ...26.09.2026, 15:00
Pankepark-Fest mit Eröffnung des neuen Teilabschnitts zwischen Panke und S-Bahnstrecke
Großes Mitmachfest mit Aktionen, Spaß und Sport
more ...